|
|
||||
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pSwiss Life Asset Management AG / Key words: Half Year Resultsbr/
Swiss Life Asset Management AG: Swiss Life REF CH ESG Swiss Properties: halfyear results with higher net income driven by improved operational...
Lire...
28/05/2026 07:00
Sandoz Group AG : Sandoz marks 80 years of antibiotics with call for urgent political action to safeguard European medicine security
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
p
Sandoz Group AG
/ Key words: Statement
br/
Sandoz marks 80 years of antibiotics with call for urgent political action to safeguard European medicine...
Lire...
28/05/2026 07:00
EQS-News: ASTA Energy Solutions AG reports strong Q1 2026 results, benefiting from accelerating market dynamics and strong commercial momentum
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: ASTA Energy Solutions AG
/ Key words: Quarterly / Interim Statement
br/
ASTA Energy Solutions AG reports strong Q1 2026 results, benefiting from accelerating market dynamics and...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: MRM Health
/ Key words: Miscellaneous
br/
MRM Health rewarded a €2.6M VLAIO Research Grant to accelerate the development of novel therapeutics that redefine the treatment of...
Lire...
28/05/2026 07:00
EQS-News: MPC Capital delivers 17% EBT growth in Q1 2026, confirms full-year outlook
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: MPC Münchmeyer Petersen Capital AG
/ Key words: Quarter Results
br/
MPC Capital delivers 17% EBT growth in Q1 2026, confirms fullyear outlook br/br/
28.05.2026 /...
Lire...
28/05/2026 07:00
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
Press Release
Sanofi’s venglustat accepted for priority review in the US to
treat type 3 Gaucher disease
Paris, May 28, 2026. The US Food and Drug Administration FDA has granted priority review
to the new drug application NDA for venglustat, a novel, investigational oral...
Lire...
28/05/2026 06:45
PURE Funds AG : PURE Swiss Opportunity REF (PSO) – completes May 2026 capital increase with a solid result.
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
pPURE Funds AG / Key words: Capital Increasebr/
PURE Swiss Opportunity REF PSO – completes May 2026 capital increase with a solid result. br/br/span28May2026 / 06:45...
Lire...
28/05/2026 06:40
Galenica AG : Galenica posts strong sales growth in a challenging market environment
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
pGalenica AG / Key words: Development of Salesbr/
Galenica posts strong sales growth in a challenging market environment br/br/span28May2026 / 06:40 CET/CEST/spanbr/
Release of an...
Lire...
28/05/2026 06:30
Dufry International AG : Avolta enters Latvia with a 12-year master concession contract at Riga Airport across retail and F&B
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
Avolta AG
/ Key words: Contract
br/
Avolta enters Latvia with a 12year master concession contract at Riga Airport across retail and F&B br/br/
28.05.2026 / 06:30...
Lire...
|
|
||||